VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
GBLI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
GBLIGlobal Indemnity Group, LLC
$25.05$359M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksGBLIQuarterly Financials

Global Indemnity Group, LLC (GBLI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Global Indemnity Group, LLC (GBLI) quarterly income statement — complete revenue, gross profit & net income history

GBLI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue109.18M116.73M114.2M110.52M108.65M108.45M111.76M108.69M112.29M109.26M126.06M141.89M150.91M155.63M194.58M147.86M130.46M189.15M166.99M164.4M
Revenue Growth %0.48%7.64%2.18%1.69%-3.24%-0.74%-11.34%-23.4%-25.59%-29.8%-35.21%-4.04%15.68%-17.72%16.53%-10.06%-17.29%19.51%4.42%-8.04%
Medical Costs & Claims0100.7M90.29M89.86M104.25M89.3M89.95M89.63M91.65M93.79M111.32M125.18M0151.17M149.34M153.72M141.39M145.63M168.48M148.15M
Medical Cost Ratio %0%86.26%79.06%81.31%95.94%82.34%80.49%82.47%81.62%85.84%88.3%88.22%0%97.13%76.75%103.96%108.38%76.99%100.89%90.12%
Gross Profit109.18M16.03M23.91M20.66M4.41M19.15M21.81M19.06M20.64M15.47M14.74M16.71M150.91M4.46M45.25M-5.86M-10.93M43.52M-1.49M16.24M
Gross Margin %100%13.74%20.94%18.69%4.06%17.66%19.51%17.53%18.38%14.16%11.7%11.78%100%2.87%23.25%-3.96%-8.38%23.01%-0.89%9.88%
Gross Profit Growth %2377.92%-16.27%9.63%8.4%-78.65%23.77%47.92%14.05%-86.32%246.57%-67.42%385.35%1480.61%-89.74%3138.82%-136.05%-189.71%268.37%-115.68%-71.94%
Operating Expenses103.66M6.83M7.84M7.53M9.5M7.02M5.92M6.38M6.37M6.73M5.28M5M150.91M2.7M14.06M6.93M7.25M13.78M7.98M9.03M
OpEx / Revenue %94.95%5.85%6.87%6.81%8.74%6.47%5.3%5.87%5.68%6.16%4.19%3.53%100%1.74%7.23%4.69%5.56%7.29%4.78%5.49%
Depreciation & Amortization01.53M1.3M1.39M1.44M1.77M1.33M1.35M1.3M1.4M1.46M1.66M1.69M1.96M3.17M1.66M1.6M4.33M1.9M2.22M
Combined Ratio %94.95%92.12%85.93%88.12%104.69%88.81%85.79%88.34%87.3%92%92.49%91.75%100%98.87%83.97%108.65%113.94%84.28%105.67%95.61%
Operating Income5.51M9.2M16.06M13.13M-5.09M12.12M15.88M12.67M14.27M8.74M9.46M11.71M01.76M31.18M-12.79M-18.19M29.74M-9.47M7.22M
Operating Margin %5.05%7.88%14.07%11.88%-4.69%11.17%14.21%11.66%12.7%8%7.51%8.25%0%1.13%16.03%-8.65%-13.94%15.72%-5.67%4.39%
Operating Income Growth %208.26%-24.07%1.13%3.59%-135.71%38.65%67.86%8.25%-396.2%-69.65%191.55%100%-94.08%429.22%-277.14%-442.23%2262.35%48.46%-83.8%
EBITDA5.51M10.72M17.37M14.52M-3.65M13.89M17.22M14.03M15.57M10.14M10.92M13.36M4.75M3.72M34.35M-11.13M-16.58M34.08M-7.57M9.44M
EBITDA Margin %5.05%9.19%15.21%13.14%-3.36%12.8%15.41%12.91%13.87%9.28%8.66%9.42%3.15%2.39%17.66%-7.53%-12.71%18.02%-4.53%5.74%
Interest Expense0002.6M0-17K017K00012K000410K2.6M2.59M2.6M2.7M
Non-Operating Income00000-17K0-17K012K0-12K-3.07M00-410K-2.6M-2.59M-2.6M-2.7M
Pretax Income5.51M9.2M16.06M13.13M-5.09M12.13M15.88M12.67M14.27M8.74M9.46M11.71M3.07M1.76M31.18M-12.79M-18.19M29.74M-9.47M7.22M
Pretax Margin %5.05%7.88%14.07%11.88%-4.69%11.19%14.21%11.66%12.7%8%7.51%8.25%2.03%1.13%16.03%-8.65%-13.94%15.72%-5.67%4.39%
Income Tax1.27M2.74M3.54M2.79M-1.1M3.11M3.13M2.58M2.9M2.84M1.76M2.37M573K-578K7.44M-626K-3.41M4.57M-1.76M844K
Effective Tax Rate %23.01%29.83%22.04%21.21%21.69%25.63%19.67%20.36%20.32%32.5%18.63%20.25%18.68%-32.82%23.85%4.9%18.77%15.36%18.57%11.69%
Net Income4.25M6.46M12.52M10.34M-3.99M9.02M12.76M10.09M11.37M5.9M7.7M9.34M2.49M2.34M23.75M-12.16M-14.77M25.18M-7.71M6.38M
Net Margin %3.89%5.53%10.97%9.36%-3.67%8.32%11.42%9.29%10.12%5.4%6.11%6.58%1.65%1.5%12.2%-8.23%-11.32%13.31%-4.62%3.88%
Net Income Growth %206.44%-28.45%-1.86%2.49%-135.1%52.97%65.71%8.1%355.73%152.16%-67.57%176.77%116.88%-90.71%407.87%-290.78%-367.77%2013.77%49.16%-83.02%
EPS (Diluted)0.290.440.860.71-0.300.650.920.730.820.430.550.670.170.151.60-0.84-1.021.74-0.530.43
EPS Growth %196.67%-32.31%-6.52%-2.74%-136.59%51.16%67.27%8.96%382.35%186.67%-65.63%179.76%116.67%-91.38%401.89%-295.35%-375.68%1988.84%50%-83.52%
EPS (Basic)0.290.440.870.72-0.300.650.930.730.830.430.560.680.170.151.63-0.84-1.021.74-0.530.43
Diluted Shares Outstanding14.4M14.35M14.22M14.16M13.87M13.79M13.8M13.68M13.69M13.57M13.81M13.71M13.93M14.59M14.8M14.54M14.52M14.45M14.45M14.68M